194 related articles for article (PubMed ID: 35432717)
1. Epithelial Membrane Protein 1 Promotes Sensitivity to RSL3-Induced Ferroptosis and Intensifies Gefitinib Resistance in Head and Neck Cancer.
Wang Y; Zhang L; Yao C; Ma Y; Liu Y
Oxid Med Cell Longev; 2022; 2022():4750671. PubMed ID: 35432717
[TBL] [Abstract][Full Text] [Related]
2. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma.
Lu T; Zhang Z; Pan X; Zhang J; Wang X; Wang M; Li H; Yan M; Chen W
J Oral Pathol Med; 2022 Jan; 51(1):52-62. PubMed ID: 34874578
[TBL] [Abstract][Full Text] [Related]
4. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
5. Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab.
Liu S; Yan S; Zhu J; Lu R; Kang C; Tang K; Zeng J; Ding M; Guo Z; Lai X; Jiang Y; Wu S; Zhou L; Sun L; Zhou ZW
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012290
[TBL] [Abstract][Full Text] [Related]
6. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.
Yang WH; Ding CC; Sun T; Rupprecht G; Lin CC; Hsu D; Chi JT
Cell Rep; 2019 Sep; 28(10):2501-2508.e4. PubMed ID: 31484063
[TBL] [Abstract][Full Text] [Related]
7. HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.
Li J; Xiao W; Wei W; Wu M; Xiong K; Lyu J; Li Y
Mol Immunol; 2023 Jun; 158():79-90. PubMed ID: 37172353
[TBL] [Abstract][Full Text] [Related]
8. Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling.
Liu S; Shi J; Wang L; Huang Y; Zhao B; Ding H; Liu Y; Wang W; Chen Z; Yang J
Free Radic Biol Med; 2022 Aug; 189():42-57. PubMed ID: 35850179
[TBL] [Abstract][Full Text] [Related]
9. Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
Jehl A; Conrad O; Burgy M; Foppolo S; Vauchelles R; Ronzani C; Etienne-Selloum N; Chenard MP; Danic A; Dourlhes T; Thibault C; Schultz P; Dontenwill M; Martin S
Cells; 2023 Feb; 12(5):. PubMed ID: 36899869
[TBL] [Abstract][Full Text] [Related]
10. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
11. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
[TBL] [Abstract][Full Text] [Related]
12. Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).
Yang M; Guo R; Chen X; Song G; Zhang F
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37052257
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
14. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
17. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
19. TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
Chen L; Lin W; Zhang H; Geng S; Le Z; Wan F; Huang Q; Chen H; Liu X; Lu JJ; Kong L
Cell Death Dis; 2024 Mar; 15(3):178. PubMed ID: 38429254
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma.
Li M; Jin S; Zhang Z; Ma H; Yang X
Cancer Lett; 2022 Feb; 527():28-40. PubMed ID: 34902522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]